<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Seizures &amp; Epilepsy (Part 3)</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Seizures &amp; Epilepsy (Part 3)</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                5 Questions | 5 Total Marks | 15 min Duration | ~180.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 5 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 15 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 5</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Seizures &amp; Epilepsy (Part 3) - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 5</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 5 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 6-year-old boy is brought to the OPD by his mother. She noticed her son has recurrent episodes of giving a blank look while playing ball games. No history is suggestive of any development delay in the child. No history of loss of consciousness and the child resumes play soon after within a few seconds. EEG performed on the child shows a characteristic 3Hz spike and waveform. The most appropriate treatment, in this case, would be?", "options": [{"label": "A", "text": "Valproate", "correct": true}, {"label": "B", "text": "Ethosuximide", "correct": false}, {"label": "C", "text": "Phenytoin", "correct": false}, {"label": "D", "text": "Carbamazepine", "correct": false}], "correct_answer": "A. Valproate", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Valproate Multiple episodes of blank look in a day with normal post-ictal phase in a 6-year -old suggests the diagnosis of Absence seizure and 3Hz spike and waveform on EEG confirms the same. Valproate is the drug of choice for Absence seizure.</p>\n<p><strong>Highyeild:</strong></p><p>Absence seizure- Age- 2 to 6 yr 30% â†’ GTCs/Myoclonic epilepsy Blank /vacant stare- seconds Unawareness â†’ during ictal â†’ nonresponsive Neuro examination/MRI- normal One of the ways to elicit and document absence seizure is hyperventilation. EEG- 3 spikes wave pattern EEG- 3 spikes wave pattern EEG showing 3 per second (3Hz) spike and wave discharges typical of absence epilepsy Treatment - Valproate Ethosuximide</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B.Ethosuximide- is preferred in children under 3 years of age due to adverse effects of Valproate -fulminant hepatitis. Option: C & D . Phenytoin and Carbamazepine are useful in GTCS.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 2.5-year-old boy with a known case of Absence seizure was prescribed Drug X. Within 2 months, the child presented to the emergency with yellowish discoloration of eyes, passing high color urine, and altered sensorium all of which started 1 day back. On examination, the child has jaundice, multiple bruises over their hands and flanks, poor GCS, and flapping tremors. Urgent LFT panel showed the following: Bilirubin- 15 mg% AST- 1000 U ALT -1450 U PT- 60 sec INR- 5 Ammonia was markedly increased A diagnosis of fulminant hepatitis was made. Regarding the adverse effect profile of drug X which statement is incorrect.", "options": [{"label": "A", "text": "Long-term use may increase the chances of PCOS in young girls", "correct": false}, {"label": "B", "text": "The given side effect is very rare with drug X", "correct": false}, {"label": "C", "text": "Bruises in a child could also be attributed to low platelet count", "correct": false}, {"label": "D", "text": "In case a pregnant female is prescribed Drug X, she should be supplemented with 400 micrograms of folic acid and fetal growth surveillance USG.", "correct": true}], "correct_answer": "D. In case a pregnant female is prescribed Drug X, she should be supplemented with 400 micrograms of folic acid and fetal growth surveillance USG.", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>In case a pregnant female is prescribed Drug X, she should be supplemented with 400 micrograms of folic acid and fetal growth surveillance USG. This is an incorrect statement .The drug X is Valproate. A pregnant patient taking valproate (high risk for NTD ) needs 4mg i.e. 4000 micrograms of folic acid supplementation. In this case, the drug used was As the patient is suffering from fulminant hepatitis ( children <3 yr are at high risk to develop fulminant hepatitis) , raised serum ammonia, and Thrombocytopenia (rash).</p>\n<p><strong>Highyeild:</strong></p><p>Sodium Valproate Mechanism of action- Blocks Na+ Blocks T type calcium channel Increases GABA Decreases glutamate Uses: Drug of choice GTCS Myoclonic seizure Absence seizure Dravet syndrome LGS-Lennox gastaut syndrome Status epilepticus Non-epileptic use Bipolar Depression Migraine DOC- rapid cycler Bipolar disorder. Adverse effects- VALPROATE V -Vomiting A -Alopecia L-Liver toxicity Fulminant hepatitis (very rare) <3 yr old is at high risk for Fulminant hepatitis P -Pancreatitis PCOD R- Requires Therapeutic Drug Monitoring Rash O -Obesity A -Ammonia increase Carnitine is DOC for Valproate hyperammonemia T -Teratogenic â†’ NTD Folate 4mg/day Thrombocytopenia E-Enzyme inhibitor</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A, B & C are true statements about Valporate.</p>\n<p><strong>Extraedge:</strong></p><p>Preconception management of epilepsy Confirm the epilepsy diagnosis Start folic acid 1 to 5 mg/day Use the most effective Antiepileptic medication at the lowest dose Avoid valproate, topiramate, and phenobarbital Establish baseline serum drug concentration.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 1-year-old child presenting with developmental regression with characteristic Salaam seizures and EEG showing a pattern of hypsarrhythmia. Drug of Choice would be?", "options": [{"label": "A", "text": "Vigabatrin", "correct": false}, {"label": "B", "text": "ACTH", "correct": true}, {"label": "C", "text": "Clonazepam", "correct": false}, {"label": "D", "text": "Ethosuximide", "correct": false}], "correct_answer": "B. ACTH", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>ACTH Patient is <2yr old with a triad of West Syndrome or infantile spasms . ACTH therapy has minimal side effects and shows a good response in reversing hypsarrhythmia . Cessation of hypsarrhythmia is more with ACTH than Vigabatrin hence hormonal therapy is preferred.</p>\n<p><strong>Highyeild:</strong></p><p>Infantile spasms/West syndrome <2 years 3-9 months Developmental delays Episodes â†’ spasm EEG-Hypsarrhythmia- Bizarre slow wave Etiology- Perinatal asphyxia Brain anomaliesâ†’ Lissencephaly Infants West syndrome Triad Salaam spells(sudden dropping of the head and flexion of arm) Developmental retardation Hypsarrhythmia Treatment- ACTH Tuberous sclerosisâ†’ Vigabatrin</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Vigabatrin -Use of Vigabatrin in West syndrome is limited only if the child has associated Tuberous Sclerosis. Option: C and D . Clonazepam and ethosuximide have no role in the treatment of West syndrome.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Concerning an indication of brain imaging in a patient with epilepsy, pick up the incorrect statement:", "options": [{"label": "A", "text": "Epilepsy before 15 years of age", "correct": true}, {"label": "B", "text": "Seizures with focal features clinically", "correct": false}, {"label": "C", "text": "Seizures refractory to treatment", "correct": false}, {"label": "D", "text": "None of the above", "correct": false}], "correct_answer": "A. Epilepsy before 15 years of age", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Epilepsy before 15 years of age</p>\n<p><strong>Highyeild:</strong></p><p>Imaging cannot establish a diagnosis of epilepsy but identifies any structural cause. It is not required if a confident diagnosis of a recognized epilepsy syndrome (e.g. juvenile myoclonic epilepsy ) can be made. CT : Structural cause of epilepsy, MRI : Subtle changes such as hippocampal sclerosis, may direct or inform surgical intervention. Indication for brain imaging in epilepsy Epilepsy starting after the age of 16 yrs Seizures having focal features clinically EEG showing a focal seizure source Control of seizures difficult or deteriorating</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B, C & D are indications for Brain imaging in patients with epilepsy.</p>\n<p><strong>Extraedge:</strong></p><p>Seizure: Clinical manifestation of abnormal and excessive excitation of a population of cortical neurons. Epilepsy: A tendency towards recurrent seizures unprovoked by systemic neurological insults. Epilepsy is a disease of the brain defined by any of the following conditions- At least 2 unprovoked (reflex) seizures occurring >24 hr apart. One unprovoked (or reflex )seizure and a probability of further seizures similar to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring over the next 10 years. Diagnosis of epilepsy syndrome. Epilepsy is considered resolved for individuals who had an age-dependent epilepsy syndrome but are now past the applicable age or those who have remained seizure-free for the last 10 years, with no seizure medicines for the last 5 years.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The commonest presentation of neurocysticercosis is", "options": [{"label": "A", "text": "Seizures", "correct": true}, {"label": "B", "text": "Focal neurological deficits", "correct": false}, {"label": "C", "text": "Dementia", "correct": false}, {"label": "D", "text": "Radiculopathy", "correct": false}], "correct_answer": "A. Seizures", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Seizures</p>\n<p><strong>Highyeild:</strong></p><p>Neurocysticercosis Most common Central nervous system Parasitic infection is Neurocysticercosis. Commonest presentation of Neurocysticercosis is Seizures. These seizures may be generalized, focal, or Jacksonian. Seizures are associated with inflammation surrounding cysticerci in the brain parenchyma. There is a wide variety of Neurocysticercosis depending on the intensity of the infestation, the localization of cysticerci, and the degree of inflammatory reaction . Cysticercosis is an infection with the larval stage (cysticercosis cellulose) of solium(Pig tapeworm) The lesion of Neurocysticercosis is readily visualized by MRI or CT scan. Parenchymal brain calcification is the most common finding on (Starry sky appearance) Brain parenchyma is the most common site of Neurocysticercosis. The ventricular system is the 2nd most common site of Most common sites of Neurocysticercosis- Parenchymatous >intraventricular> subarachnoid >spinal >orbital. These cysts are located in order of frequency in CNS(neurological manifestations are the most common) Subcutaneous tissue Striated muscle Globe of the eye Treatment Antiparasitic drugs- Albendazole Praziquantel Albendazole and praziquantel combination with more than two cystic lesions. with multiple subarachnoid cysticerci. may exacerbate the inflammatory response around the deadly parasite, thereby exacerbating seizures or hydrocephalus as well. Monitoring of the patient High Dose glucocorticoids should be used during treatment. Because glucocorticoids induce first-pass metabolism of praziquantel and may decrease its antiparasitic effect, cimetidine should be co-administered to inhibit praziquantel metabolism. Hydrocephalus treatment- Removal of the cysticercus via neurosurgery via neuro-endoscopy Microdissection using an open craniotomy Ventriculoperitoneal shunting + prolonged courses of antiparasitic drugs Patient requiring prolonged therapy- Methotrexate Tumor necrosis factor inhibitors Steroid-sparing agents Diffuse cerebral edema/Elevated intracranial pressure due to multiple inflamed lesions- Glucocorticoids(a mainstay of therapy) Antiparasitic drugs should be avoided For ocular and spinal medullary lesions, drug-induced inflammation may cause irreversible damage. Ocular disease Surgery Spinal disease Medical or surgical therapy</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B,C & D are incorrect.</p>\n<p><strong>Extraedge:</strong></p><p>TABLE 235-1 Revised Diagnostic Criteria for Neurocysticercosis 1. Absolute criteria a. Histologic demonstration of the parasite from a biopsy of a brain or spinal cord lesion b. Visualization of subretinal cysticercus c. Conclusive demonstration of a scolex within a cystic lesion on neuroimaging studies 2. Neuroimaging criteria a. Major neuroimaging criteria Cystic lesions without a discernible scolex, typical small enhancing lesions, multilobulated cystic lesions in the subarachnoid space, typical parenchymal brain calcifications b. Confirmative neuroimaging criteria Resolution of cystic lesions spontaneously or after suicidal drug therapy Migration of ventricular cysts documented on sequential neuroimaging studies c. Minor neuroimaging criteria Obstructive hydrocephalus or abnormal enhancement of basal leptomeninges 3. Clinical/exposure criteria a. Major clinical/exposure criteria Detection of specific anticysticercal antibodies (e.g., by enzyme-linked immunoelectrotransfer blot [EITB]) or cysticerci antigens by well- standardized immunodiagnostic tests Cysticercosis outside the central nervous system Evidence of a household contact with T. solium infection b. Minor clinical/exposure criteria Clinical manifestations suggestive of neurocysticercosis Individuals coming from or living in an area where cysticercosis is endemic Diagnosis is confirmed by one absolute criterion, by two major criteria or one major and one confirmatory neuroimaging criteria plus any clinical/exposure criterion, or by one major neuroimaging criterion plus two clinical/exposure criteria (including at least one major clinical/exposure criterion), together with the exclusion of other pathologies producing similar neuroimaging findings. A probable diagnosis is supported by one major neuroimaging criterion plus any two clinical/ exposure criteria or by one minor neuroimaging criterion plus at least one major clinical/exposure criterion.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error("Questions data is empty or invalid");
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error("Failed to parse questions_json:", e);
            document.getElementById(